Table 1 Characteristics of patients undergoing radiofrequency ablation (RFA)-assisted tumor enucleation (TE) for renal cell carcinoma (n = 182)
Age, years, mean (SD) | 57.6 (11.0) |
|---|---|
Male gender | 125 (68.7) |
Body mass index, kg/m2, mean (SD) | 23.3 (4.2) |
Operative time, min, median (IQR) | 100 (90–120) |
Estimated blood loss, ml, median (IQR) | 80 (50–120) |
Hospital stay, days, median (IQR) | 7 (6–8) |
Tumor size, cm, median (IQR) | 3.2 (2.8–3.9) |
Right tumor laterality | 102 (55.7) |
Follow-up, months, median (IQR) | 55.5 (45–70) |
ASA score | |
< II | 115 (63.2) |
> III | 67 (36.8) |
eGFR, ml/min/1.73m2, mean (SD) | |
Pre-operation | 64.3 (18.1) |
12 months post-operation | 60.8 (17.3) |
Tumor location | |
> 50% exophytic | 133 (73.1) |
< 50% exophytic | 41 (22.5) |
Entirely endophytic | 8 (4.4) |
Tumor position | |
Anterior | 85 (46.7) |
Posterior | 97 (53.3) |
Surgical approach | |
Laparoscopic | 170 (93.4) |
Open | 12 (6.6) |
Histology, no. patients | |
Clear cell renal cell carcinoma | 133 |
Papillary | 13 |
Oncocytoma | 10 |
Angiomyolipoma | 15 |
Chromophobe renal cell cancer | 8 |
Unclassified renal cell cancer | 3 |